Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
300015 Aier Eye Hospital Group
28.930
-0.120-0.41%
All
YOY
Do not show
Product Unit:CNY

Loading...

Industry

Loading...

Region Unit:CNY

Loading...

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

Company Overview More
The company is a well-known global chain of ophthalmic medical institutions, IPO listed medical institutions (stock code: 300015, selected into the Shanghai and Shenzhen 300th index in 2015). By 2019, more than 300 professional eye hospitals had been established in 30 provinces, cities and autonomous regions of Chinese mainland, covering more than 70 percent of the country's health insurance population and more than 6.5 million outpatients annually. In addition, there are more than 80 eye hospitals in the United States, Europe and Hong Kong, China. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry and optometry. At present, the medical network has spread throughout Chinese mainland, Hong Kong, China, Europe, the United States and Southeast Asia. It has established the strategic pattern of global development. As a professional ophthalmology chain medical institution, the company is mainly engaged in the diagnosis and treatment of all kinds of ophthalmic diseases, surgical services and medical optometry. The honors include Ayre Ophthalmology won the top 10 of China's "most respected listed companies by investors", Ayre Ophthalmology won the Best Sustainable Investment value Award, the most influential listed Company Leader Award, Gold Secret Award, Ayre Ophthalmology won the Best shareholder return Award of Chinese listed companies in 2017, and so on.
CEO: --
Market: --
Listing Date: 10/30/2009
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist